MICROPORT CARDIOFLOW
Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost impor... tance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.
MICROPORT CARDIOFLOW
Industry:
Health Care Manufacturing Medical Therapeutics
Founded:
2015-01-01
Status:
Active
Contact:
+ (86) (21) 38954600
Total Funding:
130 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Euro US Privacy User Signal Mechanism Google Analytics 4 Pound Sterling
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Investors List
Hillhouse Capital Group
Hillhouse Capital Group investment in Private Equity Round - MicroPort CardioFlow
Gamnat
Gamnat investment in Private Equity Round - MicroPort CardioFlow
CPE
CPE investment in Private Equity Round - MicroPort CardioFlow
Lake Bleu Capital
Lake Bleu Capital investment in Private Equity Round - MicroPort CardioFlow
3H Health Investment
3H Health Investment investment in Private Equity Round - MicroPort CardioFlow
China Reform Fund Management
China Reform Fund Management investment in Private Equity Round - MicroPort CardioFlow
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-31 | 4C Medical Technologies | MicroPort CardioFlow investment in Series C - 4C Medical Technologies | 35.4 M USD |